Risk Of Offensive/Incorrect Content: Blog Post » New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine

The article below may contain offensive and/or incorrect content.

In his latest message, Dr. Gordon discusses the role of NIMH and other researchers in the development of esketamine, an FDA-approved, rapid-acting medication that targets treatment-resistant depression.